COM:PROKIDNEY
ProKidney
- Stock
Last Close
1.74
22/11 21:00
Market Cap
216.27M
Beta: -
Volume Today
370.91K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 1.81M - | 2.94M 62.60% | 4.07M 38.52% | |||
average receivables | 687.50K - | |||||
book value per share | 0.20 - | 0.05 73.85% | 0.14 172.88% | -5.88 4,174.06% | -17.88 204.07% | |
capex per share | -0.02 - | -0.03 76.03% | -0.03 4.84% | -0.01 64.45% | -0.55 5,498.22% | |
capex to depreciation | -1.51 - | -5.66 276.02% | -2.62 53.76% | -0.61 76.77% | -10.79 1,674.74% | |
capex to operating cash flow | 0.02 - | 0.22 1,175.22% | 0.10 52.36% | 0.02 76.80% | 0.38 1,485.53% | |
capex to revenue | ||||||
cash per share | 0.19 - | 0.02 87.34% | 0.11 349.06% | 2.63 2,284.73% | 5.88 123.73% | |
days of inventory on hand | ||||||
days payables outstanding | 587.18 - | |||||
days sales outstanding | ||||||
debt to assets | 0.09 - | 0.03 64.54% | 0.00 86.01% | 0.01 126.57% | ||
debt to equity | 0.16 - | 0.05 68.64% | -0.00 104.41% | -0.00 82.82% | ||
dividend yield | ||||||
earnings yield | -0.10 - | -0.01 85.85% | -0.03 110.53% | -0.12 287.66% | -0.32 178.85% | |
enterprise value | 778.67K - | 1.88B 241,657.29% | 1.83B 2.94% | 791.54M 56.68% | 53.62M 93.23% | |
enterprise value over ebitda | -42.57 - | -72.36 69.97% | -34.39 52.47% | -5.50 84.02% | -0.36 93.43% | |
ev to operating cash flow | -10.14 - | -74.76 637.40% | -36.33 51.41% | -10.27 71.73% | -0.60 94.20% | |
ev to sales | ||||||
free cash flow per share | -0.99 - | -0.16 83.49% | -0.30 81.12% | -0.42 42.25% | -2.01 375.75% | |
free cash flow yield | -0.10 - | -0.02 83.49% | -0.03 84.97% | -0.06 105.29% | -1.13 1,733.50% | |
graham net net | 0.15 - | -0.01 108.27% | 0.04 417.85% | 2.56 6,548.95% | 5.42 112.00% | |
graham number | 2.15 - | 0.41 80.77% | 0.98 137.19% | 10.25 946.13% | 15.21 48.33% | |
income quality | 0.96 - | 0.94 2.42% | 0.91 3.11% | 0.52 42.95% | 2.54 387.98% | |
intangibles to total assets | 0.04 - | 0.04 12.05% | 0.01 72.37% | 0.00 96.13% | 0 100% | |
interest coverage | -711.66 - | -12.63K 1,674.28% | ||||
interest debt per share | 0.01 - | 0.01 14.43% | 0.01 95.95% | 0.07 411.57% | ||
inventory turnover | ||||||
invested capital | 0.16 - | 0.05 68.64% | -0.00 104.41% | -0.00 82.82% | ||
market cap | 793.90K - | 1.89B 237,400.96% | 1.85B 2.08% | 1.28B 30.71% | 109.85M 91.41% | |
net current asset value | 11.70K - | -1.25M 10,792.31% | 13.89M 1,210.31% | 491.66M 3,439.68% | 344.93M 29.84% | |
net debt to ebitda | 0.83 - | 0.12 86.06% | 0.36 211.84% | 3.39 836.32% | 0.38 88.81% | |
net income per share | -1.01 - | -0.14 85.85% | -0.30 106.16% | -0.79 168.62% | -0.57 27.64% | |
operating cash flow per share | -0.98 - | -0.14 86.20% | -0.27 99.75% | -0.41 53.26% | -1.46 253.08% | |
payables turnover | 0.62 - | |||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -4.25 - | -1.67 60.77% | -1.38 16.97% | -0.29 79.32% | -0.08 70.52% | |
revenue per share | ||||||
roe | -5.01 - | -2.71 45.90% | -2.05 24.45% | 0.14 106.59% | 0.03 76.20% | |
roic | -1.21 - | -2.06 70.31% | -1.86 9.68% | 0.14 107.56% | 0.14 2.66% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | 0.20 - | 0.05 73.85% | 0.14 172.88% | -5.88 4,174.06% | -17.88 204.07% | |
stock based compensation to revenue | ||||||
tangible asset value | 15.03K - | 9.22M 61,273.62% | 26.49M 187.24% | 504.73M 1,805.42% | 391.34M 22.47% | |
tangible book value per share | 0.19 - | 0.05 72.36% | 0.14 172.88% | 2.71 1,775.12% | 6.34 134.31% | |
working capital | 12.71K - | 83K 553.03% | 14.96M 17,920.48% | 493.85M 3,201.77% | 349.11M 29.31% |
All numbers in (except ratios and percentages)